Urinary sediment miRNA levels in adult nephrotic syndrome

Clinica Chimica Acta

Volumn 418, Issue , 2013, Pages 5-11

  Wang, Gang ^a,b   Kwan, Bonnie Ching Ha ^a   Lai, Fernand Mac Moune ^a   Chow, Kai Ming ^a   Li, Philip Kam Tao ^a   Szeto, Cheuk Chun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

Author keywords

Biomarker; Glomerulonephritis; Proteinuria

Indexed keywords

MICRORNA; MICRORNA 192; MICRORNA 200C; MICRORNA 29A; MICRORNA 638; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; FOCAL GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; POST HOC ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; URINALYSIS; URINE SEDIMENT;

FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEPHROTIC SYNDROME;

EID: 84872766915     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.12.011     Document Type: Article

References (33)

1. De Seigneux S., Martin P.Y. Management of patients with nephrotic syndrome. Swiss Med Wkly 2009, 139:416-422.
2. Mathieson P.W. Minimal change nephropathy and focal segmental glomerulosclerosis. Semin Immunopathol 2007, 29:415-426.
3. Ronco P., Debiec H. Pathogenesis of membranous nephropathy: recent advances and future challenges. Nat Rev Nephrol 2012, 8:203-213.
4. Blázquez-Medela A.M., López-Novoa J.M., Martínez-Salgado C. Mechanisms involved in the genesis of diabetic nephropathy. Curr Diabetes Rev 2010, 6:68-87.
5. Traum A.Z. Urine proteomic profiling to identify biomarkers of steroid resistance in pediatric nephrotic syndrome. Expert Rev Proteomics 2008, 5:715-719.
6. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011, 12:861-874.
7. Jiang Q., Wang Y., Hao Y., et al. miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res 2009, 37:D98-D104.
8. Xiong M., Jiang L., Zhou Y., et al. The miR-200 family regulates TGF-beta1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Am J Physiol Renal Physiol 2012, 302:F369-F379.
9. Putta S., Lanting L., Sun G., Lawson G., Kato M., Natarajan R. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. J Am Soc Nephrol 2012, 23:458-469.
10. Zhong X., Chung A.C., Chen H.Y., Meng X.M., Lan H.Y. Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol 2011, 22:1668-1681.
11. Wang B., Komers R., Carew R., et al. Suppression of microRNA-29 expression by TGF-beta1 promotes collagen expression and renal fibrosis. J Am Soc Nephrol 2012, 23:252-265.
12. Lu J., Kwan B.C., Lai F.M., et al. Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis. Nephrology (Carlton) 2012, 17:346-351.
13. Zhou H., Hasni Sarfaraz A., Tandon Mayank, et al. Renal Mir-150 as potential biomarker of chronicity in lupus nephritis. Arthritis Rheum 2011, 63(Suppl. 10):1382-1385.
14. Kato M., Arce L., Natarajan R. MicroRNAs and their role in progressive kidney diseases. Clin J Am Soc Nephrol 2009, 4:1255-1266.
15. Wang G., Kwan B.C., Lai F.M., Chow K.M., Kam-Tao Li P., Szeto C.C. Expression of microRNAs in the urinary sediment of patients with IgA nephropathy. Dis Markers 2010, 28:79-86.
16. Wang G., Kwan B.C., Lai F.M., et al. Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis. Am J Hypertens 2010, 23:78-84.
17. Mitch W. Measuring the rate of progression of renal insufficiency. The progressive nature of renal disease 1986, 203-220. Churchill Livingstone Inc., New York. W.E. Mitch, JS, BMB (Eds.).
18. Chan R.W., Tam L.S., Li E.K., et al. Inflammatory cytokine gene expression in the urinary sediment of lupus nephritis patients. Arthritis Rheum 2003, 48:1326-1331.
19. Szeto C.C., Kwan B.C., Lai K.B., et al. Micro-RNA expression in the urinary sediment of patients with chronic kidney diseases. Dis Markers 2012, 33:137-144.
20. Helsel D.R. Less than obvious - statistical treatment of data below the detection limit. Environ Sci Technol 1990, 24:1766-1774.
21. Wang G., Lai F.M., Tam L.S., et al. Messenger RNA expression of podocyte associated molecules in the urinary sediment of patients with lupus nephritis. J Rheumatol 2007, 34:2358-2364.
22. Ho J., Kreidberg J.A. The long and short of microRNAs in the kidney. J Am Soc Nephrol 2012, 23:400-404.
23. Chen X., Ba Y., Ma L., et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008, 18:997-1006.
24. Wang G., Tam L.S., Kwan B.C., et al. Expression of miR-146a and miR-155 in the urinary sediment of systemic lupus erythematosus. Clin Rheumatol 2012, 31:435-440.
25. Lan H.Y. Transforming growth factor-β/Smad signalling in diabetic nephropathy. Clin Exp Pharmacol Physiol 2012, 39:731-738.
26. Marques F.Z., Campain A.E., Tomaszewski M., et al. Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs. Hypertension 2011, 58:1093-1098.
27. Li J.Y., Yong T.Y., Michael M.Z., Gleadle J.M. The role of microRNAs in kidney disease. Nephrology (Carlton) 2010, 15:599-608.
28. Kato M., Zhang J., Wang M., et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A 2007, 104:3432-3437.
29. Krupa A., Jenkins R., Luo D.D., Lewis A., Phillips A., Fraser D. Loss of microRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol 2010, 21:438-447.
30. Wendlandt E.B., Graff J.W., Gioannini T.L., McCaffrey A.P., Wilson M.E. The role of MicroRNAs miR-200b and miR-200c in TLR4 signaling and NF-κB activation. Innate Immun 2012, 18:846-855.
31. Lerner M., Haneklaus M., Harada M., Grandér D. MiR-200c regulates Noxa expression and sensitivity to proteasomal inhibitors. PLoS One 2012, 7:e36490.
32. Noren Hooten N., Abdelmohsen K., Gorospe M., Ejiogu N., Zonderman A.B., Evans M.K. microRNA expression patterns reveal differential expression of target genes with age. PLoS One 2010, 5:e10724.
33. Ohyashiki M., Ohyashiki J.H., Hirota A., Kobayashi C., Ohyashiki K. Age-related decrease of miRNA-92a levels in human CD8+ T-cells correlates with a reduction of naive T lymphocytes. Immun Ageing 2011, 8:11-15.